The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Accounts receivable, related party | - | 0 |
| Accounts receivable | - | 205,534 |
| Non-cash lease expense | - | 0 |
| Accounts payable | - | 455,366 |
| Net loss | -225,902 | -535,861 |
| Depreciation | 5,396 | 12,775 |
| Common stock issued for services | 0 | 2,586 |
| Stock-based compensation, stock options | 21,127 | 54,067 |
| Accounts receivable-Nonrelated Party | 245,428 | - |
| Other current assets | -121,905 | -157,985 |
| Right-of-use asset | 187,408 | -277,029 |
| Accounts payable-Nonrelated Party | 215,723 | - |
| Accounts payable-Related Party | 137,764 | - |
| Deferred revenue | -125,000 | 250,000 |
| Accrued expenses | 99,939 | -105,630 |
| Operating lease liability | 187,408 | -277,029 |
| Net cash (used in) operating activities | -244,308 | 85,754 |
| Purchase of property and equipment | - | 0 |
| Net cash used in investing activities | - | 0 |
| Proceeds received on exercise of warrants | 0 | 14,800 |
| Repayments on notes payable | 85,071 | 190,035 |
| Net cash provided by/(used in) financing activities | -85,071 | -175,235 |
| Net change in cash and cash equivalents | -329,379 | -89,481 |
| Cash and cash equivalents at beginning of period | 2,395,405 | - |
| Cash and cash equivalents at end of period | 1,976,545 | - |
Syra Health Corp (SYRA)
Syra Health Corp (SYRA)